The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 18) highlights the autoimmune category. As different formulations with different administration routes emerge, it’s increasingly important to manage across the medical and pharmacy benefits. We also discuss updates around biosimilars in the space, including a pipeline.  

Other Spring issue highlights:    

• Advances and management challenges in gene therapies  
• Prime’s IntegratedRx solutions for oncology and cystic fibrosis 
• Results from a Prime precision oncology clinical program that evaluated real-world operational processes in biomarker testing 
• Update on GLP-1 treatments 
• Pipeline update 

Explore the report